StockData
IceCure Medical Ltd. logo

IceCure Medical Ltd. (ICCM) stock

ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026Score 2/30
$0.73+0.03 (+4.29%)

Close on Nov 13, 2026Market cap $2.50MP/E 0.1Yield –

Earnings

IceCure Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2025
$525.00K
EPS, Q2 FY2025
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of IceCure Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 12, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Jan 12, 2026before the open–––Release
Q2 FY2025ended Jun 30, 2025Jul 3, 2025before the open$525.00K––Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025before the open–––Release
Q4 FY2023ended Dec 31, 2023Jan 10, 2024before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 14, 2023before the open–––Release
Q4 FY2022ended Dec 31, 2022Feb 9, 2023before the open–––Release
Q2 FY2022ended Jun 30, 2022Aug 15, 2022after the close–––Release
Q4 FY2021ended Dec 31, 2021Jan 31, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

IceCure Medical has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When IceCure Medical puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases IceCure Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?